HITRUST-Certified Security Safeguards Corporate Integration; Simplified Vancomycin Dosing Aligned with AUC Guidelines Boosts Pharmacist Confidence and Standardization

DoseMe, a leader in model-informed precision dosing (MIPD), today announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in alignment with Area Under the Curve (AUC) guidelines. This advancement ensures standardized, efficient dosing practices across its team of three pharmacists, who manage a patient population of 600 outpatients.

The decision to adopt DoseMeRx followed a thorough evaluation by multiple departments, including IT and leadership. DoseMeRx stood out for its robust IT security features, based on its HITRUST certifications, and its intuitive interface.

The Program of All-Inclusive Care for the Elderly (PACE) offers a variety of services, many of which are provided onsite at a Senior Care Partners (PACE) Center. Senior Care Partners (PACE) serves as an alternative to nursing home care, coordinating preventive, primary, acute, and long-term care services through an interdisciplinary care team (IDT) composed of physicians, nurse practitioners, nurses, social workers, therapists, van drivers, and aides, enabling older individuals to continue living in the community.

“With infrequent cases requiring vancomycin dosing, we recognized the need for a standardized approach to improve consistency and confidence among our pharmacists,” said Gianna Balazs, PharmD, BCGP, Pharmacy Department Leader/Lead Clinical Pharmacist at Senior Care Partners (PACE). “DoseMeRx provides a clear, precise methodology that reduces variability and enhances the quality of care we deliver to our patients.”

Senior Care Partners (PACE) had historically relied on trough-based dosing and manual calculations. The organization sought a solution to streamline its processes while supporting pharmacists with varying levels of experience.

“DoseMeRx not only standardizes reporting and documentation but also equips pharmacists with accessible resources for more confident decision-making,” stated Sharmeen Roy, Chief Science and Strategy Officer at DoseMe. “While Senior Care Partners (PACE) currently focuses on vancomycin dosing, the success of DoseMeRx lays the groundwork for expanding other therapeutic models as needed.”

“Compared to other programs, DoseMeRx demonstrated superior security, functionality, and ease of use,” added Balazs. “Our team quickly acclimated to the platform through video tutorials and trial scenarios, making the transition seamless.”

For information on the models available from DoseMe visit https://doseme-rx.com/why-dosemerx/drug-packages.

About DoseMe

DoseMe combines smart technology with science, leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250127369863/en/